Devices descending from K161510
1 later device reach VTEK 2 AST-GN Ceftolozane/Tazobactam (<=0.25 - >= 32 mcg/mL) through their predicates, nearest generation first.
| Generation | Number | Device | Applicant | Decided | Own descendants | Recalls |
|---|---|---|---|---|---|---|
| +1 | K172944 | VITEK 2 AST-GN Ceftazidime/Avibactam <=0.12 – >=16 µg/mL | bioMerieux, Inc. | 2017 | 0 | 1 |